Proteomics and other omics can be used to screen for various diseases throughout life. Proteins expressed at different levels can be markers for increased risk, or actual incidence of disease or condition. Our research into protein biomarkers aims to identify and characterize links between expression of these markers and adverse pregnancy outcomes.
